Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Files

557500.pdf (303.35 KB)

Document type

Article

Version

Published version

Publication date

2007

All rights reserved

Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/18628

Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

http://dx.doi.org/10.1136/gut.2006.107789

Abstract

Hepatorenal syndrome (HRS) is a serious complication of end-stage liver disease, occurring mainly in patients with advanced cirrhosis and ascites, who have marked circulatory dysfunction,1 as well as in patients with acute liver failure.2 In spite of its functional nature, HRS is associated with a poor prognosis,3 4 and the only effective treatment is liver transplantation. During the 56th Meeting of the American Association for the Study of Liver Diseases, the International Ascites Club held a Focused Study Group (FSG) on HRS for the purpose of reporting the results of an international workshop and to reach a consensus on a new definition, criteria for diagnosis and recommendations on HRS treatment. A similar workshop was held in Chicago in 1994 in which standardised nomenclature and diagnostic criteria for refractory ascites and HRS were established.5 The introduction of innovative treatments and improvements in our understanding of the pathogenesis of HRS during the previous decade led to an increasing need to undertake a new consensus meeting. This paper reports the scientific rationale behind the new definitions and recommendations. The international workshop included four issues debated by four panels of experts (see Acknowledgements). The issues were: (1) evidence-based HRS pathogenesis; (2) treatment of HRS using vasoconstrictors; (3) other HRS treatments using transjugular intrahepatic portosystemic stent-shunt (TIPS) and extracorporeal albumin dialysis (ECAD); and (4) new definitions and diagnostic criteria for HRS and recommendations for its treatment.

Subject

Cirrosi hepàtica, Malalties del ronyó, Diagnòstic, Medicina preventiva, Terapèutica

Subject (English)

Hepatic cirrhosis, Kidney diseases, Diagnosis, Preventive medicine, Therapeutics

Citation

Collections

Articles publicats en revistes (Medicina)

Citation

SALERNO, Francesco, et al. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut. 2007. Vol. 56, num. 9, pags. 1310-1318. ISSN 0017-5749. [consulted: 10 of August of 2026]. Available at: https://hdl.handle.net/2445/18628

Export metadata

JSON - METS

Share record